Soft Mist Inhaler for PAH (with unnamed Pharma Partner)
Pulmonary Arterial Hypertension
Not DisclosedActive
Key Facts
About Resyca
Resyca BV is a private, Netherlands-based company that has established itself as a specialist in innovative soft mist drug delivery platforms. Its core technologies, the PFSI™ (pre-filled syringe inhaler) and Pulmospray®/Ultra Soft Nasal Pump Spray systems, are designed to aerosolize liquid formulations—including sensitive biologics and high-dose drugs—for targeted lung and nasal cavity delivery. Operating as a B2B platform and development partner, Resyca collaborates with pharmaceutical companies to accelerate combination products to market, leveraging clinically validated, IP-protected devices that align with sustainability goals by avoiding propellants.
View full company profileTherapeutic Areas
Other Pulmonary Arterial Hypertension Drugs
| Drug | Company | Phase |
|---|---|---|
| Tadliq® (Tadalafil Oral Suspension) | CMP Pharma | Approved |
| Technosphere Platform (Partnered: Tyvaso DPI) | MannKind | Approved |
| JTV-161 | Akros Pharma | Phase1 |
| PROPHET | Occlutech | Pilot |
| LTSE-2578 | Structure Therapeutics | Phase 1 |
| Tyvaso DPI® | MannKind Corp | Approved |
| F230 | Gyre Therapeutics | Not Specified |